Design Therapeutics Inc (DSGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DSGN | AZN | AMGN | GILD | VRTX |
| Company | Design Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 9.46 | 92.39 | 328.77 | 122.49 | 454.34 |
| High | 9.71 | 92.45 | 329.19 | 122.59 | 455.99 |
| Low | 8.94 | 91.17 | 325.01 | 121.19 | 448.52 |
| Latest | 9.10 | 91.57 | 327.64 | 121.60 | 452.13 |
| Change | -0.28 | -0.36 | +0.33 | -1.14 | -1.23 |
| % Change | -2.99% | -0.39% | +0.10% | -0.93% | -0.27% |
| Volume | 220,081 | 3,557,348 | 1,533,419 | 4,525,090 | 824,359 |
| 20-Day Average Volume | 485,057 | 4,664,388 | 2,876,037 | 6,640,172 | 1,204,747 |
| Previous Close | 9.38 | 91.93 | 327.31 | 122.74 | 453.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 9.51 | 91.26 | 326.43 | 122.36 | 453.11 |
| 20-Day Raw Stochastic | 37.25% | 59.95% | 45.32% | 36.58% | 58.13% |
| 20-Day Relative Strength | 52.99 | 56.21 | 52.34 | 47.99 | 54.84 |
| Weighted Alpha | +105.42 | +40.22 | +24.78 | +28.55 | +10.50 |
| Today's Opinion | 88% Buy | 100% Buy | 96% Buy | 48% Buy | 56% Buy |
| Previous Opinion | 88% Buy | 100% Buy | 80% Buy | 64% Buy | 56% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | 88% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.26% since 12/24/25 | -0.95% since 12/24/25 | -1.85% since 12/24/25 | -3.28% since 12/24/25 | -2.46% since 12/24/25 |
| Low | 8.94 on 01/02/26 | 91.17 on 01/02/26 | 325.01 on 01/02/26 | 121.19 on 01/02/26 | 448.58 on 01/02/26 |
| High | 10.01 on 12/30/25 | 92.91 on 12/26/25 | 333.98 on 12/26/25 | 125.77 on 12/26/25 | 463.65 on 12/26/25 |
| 1-Month | |||||
| %Chg | +2.13% since 12/02/25 | +1.55% since 12/02/25 | -3.13% since 12/02/25 | -1.90% since 12/02/25 | +4.26% since 12/02/25 |
| Low | 8.43 on 12/19/25 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 433.81 on 12/10/25 |
| High | 10.31 on 12/05/25 | 93.10 on 12/23/25 | 346.38 on 12/03/25 | 127.41 on 12/23/25 | 464.44 on 12/24/25 |
| 3-Month | |||||
| %Chg | +51.79% since 10/02/25 | +9.47% since 10/02/25 | +10.21% since 10/02/25 | +9.94% since 10/02/25 | +10.46% since 10/02/25 |
| Low | 5.28 on 10/22/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 109.66 on 10/03/25 | 400.73 on 10/06/25 |
| High | 10.31 on 12/05/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 464.44 on 12/24/25 |
| 6-Month | |||||
| %Chg | +148.10% since 07/02/25 | +28.74% since 07/02/25 | +10.42% since 07/02/25 | +9.00% since 07/02/25 | -1.18% since 07/02/25 |
| Low | 3.52 on 07/08/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 |
| High | 10.31 on 12/05/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 534,322 | 285,116,480 | 176,250,224 | 152,281,072 | 115,026,040 |
| Shares Outstanding, K | 56,964 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -49,590,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -17,000,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.63 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.30 on 11/05/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/09/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.24 | 15.03 | 15.04 | 29.64 |